July 29, 2014 | By DEEPTI RAMESH
Lonza reports huge rise in profits Lonza recorded net profits of 140 million Swiss francs ($155 million) for the first half of 2014 compared with profits of SF41 million in the first half of 2013. Sales for the first half of 2014 increased by 3.2% compared with the year-ago period, to SF1.80 billion. In the first half of 2014, Lonza’s specialty ingredients and pharma and biotech market segments both...
July 25, 2014 | By LINDSAY FROST
This Week in CW: Earnings season is in full swing as several companies reported results this week. BASF reported a 12.3% increase in second-quarter net income, to €1.3 billion ($1.7 billion), on 0.6% higher sales, €18.5 billion. Dow Chemical's second-quarter results beat estimates as margins improved in its performance plastics segment and sales increased across all of the company's business...
July 23, 2014 | By ROB WESTERVELT
Air Products chairman and CEO Seifi Ghasemi, who took the helm of the company on 1 July, says that a focus cash generation and improved capital allocation will drive company strategy....
July 18, 2014 | By LINDSAY FROST
This Week in CW: Albemarle has reached an agreement to acquire Rockwood Holdings, a leading producer of lithium and surface treatment chemicals, for $6.2 billion. The deal gives Albemarle, a leading producer of catalysts and bromine-based derivatives, first or second position across four high-margin specialty chemical segments that are all growing at or faster than GDP, Albemarle says. “All four...
July 16, 2014 | By LAWRENCE SLOAN, SOCMA PRESIDENT AND CEO
Last week’s passage of H.R. 4007—The Chemical Facility Anti-Terrorism Standards (CFATS) Authorization and Accountability Act of 2014—by the US House of Representatives is a huge step forward in gaining long-term authorization of CFATS and improving our nation’s chemical security. Socma worked closely with Congressional staff to create and move this bill...
July 11, 2014 | By VINCENT VALK
This Week on CW: German personal care chemicals maker Hansa Group has filed for insolvency after reviewing a variety of restructuring options. The company reported €398.9 million ($544.2 million) in revenue and just €1.2 million in profit in 2012, the most recently available data. US Congress has passed a reauthorization of the Chemical Facility Anti-Terrorism Standards (CFATS) act, which extends...
July 8, 2014 | By DEEPTI RAMESH
Medichem opens HPAPI plant in Malta Active pharmaceutical ingredients (API) manufacturer Medichem (Barcelona, Spain) says it has opened a new high potency API (HPAPI) plant in the company's manufacturing site at Hal Far, Malta. “Our expansion into the field of HPAPIs will allow Medichem to offer a broader product portfolio to our customers. Currently, 25% of new drugs in development are highly...
July 1, 2014 | By DEEPTI RAMESH
Feature FDA tightens control over India’s API manufacturers FDA has, since 2013, issued warning letters to several active pharmaceutical ingredient (API) manufacturing facilities in India. According to figures from the FDA Web site, warning letters were issued in 2011 to three API manufacturing facilities in India, but no such warnings were issued in 2012. Experts say the recent rise in letters to...
June 27, 2014 | By LINDSAY FROST
This Week in CW: IHS Chemical's annual Polyethylene Polypropylene Chain Global Business Forum (PEPP) took place in Zurich this week. Asia will remain the main demand region for polyolefins, and its share of worldwide polyolefin consumption will exceed 50% by 2020, with China representing well over half of this share, says Ajay Shah, senior executive v.p./chemicals at Reliance Industries at a presentation...
June 24, 2014 | By DEEPTI RAMESH
FDA issues warning letters to API plants in China and India FDA issued separate warning letters earlier this month to the active pharmaceutical ingredient (API) manufacturing facilities of Tianjin Zhongan Pharmaceutical (Tianjin, China) and Apotex (Toronto) located at Tianjin; and Bangalore, India, respectively, for violating cGMP. The warning letters were published on the FDA Web site last week. FDA...
ABOUT CHEM IDEAS
Welcome to Chem Ideas, the place for opinions and perspective on the key issues affecting the global chemicals industry. This zone features articles by Chemweek’s regular editors as well as a team of established experts with insights across the chemicals industry. If you would like to contribute a blog or opinion piece contact Lindsay.Frost@ihs.com.
CLICK HERE TO LEARN ABOUT CHEMWEEK'S EDITORS
ABOUT OUR GUEST AUTHORS
Fine Chemicals / Pharma
Girish Malhotra is the president and founder of Epcot International, an international consulting firm covering chemical manufacture. Girish is an established industry figure having held senior positions at companies including ExxonMobil and Sherwin Williams. He can be reached at email@example.com
Lawrence D. Sloan became Socma's
President in early 2010. He says he will continue to drive up the interests of his members on issues including regulation and best business practice.
Lisa Allen is the Technical Manager of ReachReady, the Reach services body affiliated to the Chemical Industries Assocation (CIA; U.K.).
She spends much of her time addressing concerns raised by ReachReady’s customers about Reach.
Kathryn Sheridan is the founder of Sustainability Consult, providing public relations support with a sustainability focus to a number of chemical industry clients, as well as to other sectors. Sustainability Consult helps organisations develop, promote and communicate their sustainability strategies, plans and activities. firstname.lastname@example.org
Rubber and Plastics
Lou Reade is a freelance journalist and expert in the rubber and plastics fields. Based in the U.K. Lou has more than a decade writing in about rubber and plastics manufacture with a wealth of experience gained while writing for the leading publications in the field in the U.K. and wider afield. Loureade@talk21.com.
Giles Chappell is an attorney based in Geneva. His practice focuses on chemicals—specifically REACH and the CLP Regulation, product safety legislation, environmental and trade compliance, and market access issues. He was recommended in 2012 by the Chambers & Partners legal directory. email@example.com
Steve Roberts is an attorney who practices in the rapidly developing area of homeland security law and regulation. Steve writes and speaks frequently on the legal aspects of homeland security and counterterrorism affecting the nation’s critical infrastructure. www.chemicalsecurity.com